AI29182/AI/NIAID NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
1992	1
1993	2
1994	1
1995	2
1996	2
1999	1
2000	2
2024	0

1

Mosier DE. Mosier DE. Semin Immunol. 1996 Aug;8(4):255-62. doi: 10.1006/smim.1996.0032. Semin Immunol. 1996. PMID: 8883149 Review.

2

Macrophage-tropic HIV: critical for AIDS pathogenesis?

Mosier D, Sieburg H. Mosier D, et al. Immunol Today. 1994 Jul;15(7):332-9. doi: 10.1016/0167-5699(94)90081-7. Immunol Today. 1994. PMID: 7916189 Review.

3

Human xenograft models for virus infection.

Mosier DE. Mosier DE. Virology. 2000 Jun 5;271(2):215-9. doi: 10.1006/viro.2000.0336. Virology. 2000. PMID: 10860873 Free article. Review. No abstract available.

4

Differential Epstein-Barr virus gene expression in B-cell subsets recovered from lymphomas in SCID mice after transplantation of human peripheral blood lymphocytes.

Rochford R, Mosier DE. Rochford R, et al. J Virol. 1995 Jan;69(1):150-5. doi: 10.1128/JVI.69.1.150-155.1995. J Virol. 1995. PMID: 7983705 Free PMC article.

5

Transfer of human chronic lymphocytic leukemia to mice with severe combined immune deficiency.

Kobayashi R, Picchio G, Kirven M, Meisenholder G, Baird S, Carson DA, Mosier DE, Kipps TJ. Kobayashi R, et al. Leuk Res. 1992 Oct;16(10):1013-23. doi: 10.1016/0145-2126(92)90081-h. Leuk Res. 1992. PMID: 1383641

6

Highly potent RANTES analogues either prevent CCR5-using human immunodeficiency virus type 1 infection in vivo or rapidly select for CXCR4-using variants.

Mosier DE, Picchio GR, Gulizia RJ, Sabbe R, Poignard P, Picard L, Offord RE, Thompson DA, Wilken J. Mosier DE, et al. J Virol. 1999 May;73(5):3544-50. doi: 10.1128/JVI.73.5.3544-3550.1999. J Virol. 1999. PMID: 10196243 Free PMC article.

7

Human immunodeficiency virus infection of human cells transplanted to severe combined immunodeficient mice.

Mosier DE. Mosier DE. Adv Immunol. 1996;63:79-125. doi: 10.1016/s0065-2776(08)60855-x. Adv Immunol. 1996. PMID: 8787630 Review. No abstract available.

8

Altered viral fitness of HIV-1 following failure of protease inhibitor-based therapy.

Picchio GR, Valdez H, Sabbe R, Landay AL, Kuritzkes DR, Lederman MM, Mosier DE. Picchio GR, et al. J Acquir Immune Defic Syndr. 2000 Dec 1;25(4):289-95. doi: 10.1097/00042560-200012010-00001. J Acquir Immune Defic Syndr. 2000. PMID: 11114828 Clinical Trial.

9

Rapid loss of CD4+ T cells in human-PBL-SCID mice by noncytopathic HIV isolates.

Mosier DE, Gulizia RJ, MacIsaac PD, Torbett BE, Levy JA. Mosier DE, et al. Science. 1993 Apr 30;260(5108):689-92. doi: 10.1126/science.8097595. Science. 1993. PMID: 8097595

10

Protection against HIV-1 infection in hu-PBL-SCID mice by passive immunization with a neutralizing human monoclonal antibody against the gp120 CD4-binding site.

Parren PW, Ditzel HJ, Gulizia RJ, Binley JM, Barbas CF 3rd, Burton DR, Mosier DE. Parren PW, et al. AIDS. 1995 Jun;9(6):F1-6. doi: 10.1097/00002030-199506000-00001. AIDS. 1995. PMID: 7662189

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

11 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

11 results

Results by year